Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial

« Previous Article | Table of Contents | Next Article »

Circulation. 1993;87:38-52

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Request Permissions

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Search for Related Content

PubMed

	PubMed Citation

ARTICLES

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial

BACKGROUND. The early effects of tissue-type plasminogen activator (t- PA) on the "culprit" coronary lesion in patients presenting with unstable angina or non-Q wave myocardial infarction were determined by quantitative arteriography. METHODS AND RESULTS. Of 391 such patients, 306 satisfied clinical and arteriographic requirements for eligibility and received a 90-minute front-loaded infusion of t-PA (0.8 mg/kg i.v.; maximum, 80 mg) or placebo plus conventional antianginal therapy. All patients received full heparinization and a follow-up arteriogram 18-48 hours after treatment. A non-Q wave myocardial infarction (MI) was diagnosed in 97 patients (32%) after entry. In the entire patient population, among t-PA- and placebo-treated patients, respectively, 25% versus 19% (p = 0.25) of all culprit lesions achieved the primary study end point, measurable improvement (by > or = 10% reduction of stenosis or two Thrombolysis in Myocardial Infarction [TIMI] flow grades) at follow-up. Substantial improvement (by > or = 20% reduction of stenosis or two TIMI grades) was seen with t-PA in 15% of all culprit lesions versus 5% with placebo (p < 0.003). Arteriographically apparent thrombus was present at baseline in the culprit lesion of 107 patients (35%). Substantial improvement was more frequent with t-PA among lesions containing apparent thrombus (in 36% with t-PA versus 15% with placebo; p < 0.01), as it was among patients evolving a non-Q wave MI (33% versus 8%; p < 0.005). By multivariate analysis, the significant, independent predictors of substantial improvement include apparent thrombus (p = 0.0001), non-Q wave MI (p = 0.003), and t-PA use (p = 0.01). Both non-Q wave MI status and thrombus had been specified a priori as important variables. CONCLUSIONS. Arteriographically apparent intraluminal thrombus and improvement of the culprit lesion with either of these regimens were only moderately frequent in patients with unstable angina or non-Q wave MI. Substantial improvement of culprit lesions was more frequent with t-PA than with placebo overall and in two prospectively defined subgroups. The clinical relevance of these observations is being tested in the larger, ongoing clinical TIMI IIIB study.

This article has been cited by other articles:

A. Kumar and C. P. Cannon
Acute Coronary Syndromes: Diagnosis and Management, Part I
Mayo Clin. Proc., October 1, 2009; 84(10): 917 - 938.
[Abstract] [Full Text] [PDF]

G. Sardella, M. Mancone, C. Bucciarelli-Ducci, L. Agati, R. Scardala, I. Carbone, M. Francone, A. Di Roma, G. Benedetti, G. Conti, et al.
Thrombus Aspiration During Primary Percutaneous Coronary Intervention Improves Myocardial Reperfusion and Reduces Infarct Size The EXPIRA (Thrombectomy With Export Catheter in Infarct-Related Artery During Primary Percutaneous Coronary Intervention) Prospective, Randomized Trial.
J. Am. Coll. Cardiol., January 27, 2009; 53(4): 309 - 315.
[Abstract] [Full Text] [PDF]

B Kunadian, J Dunning, R Das, A P Roberts, R Morley, A J Turley, D Twomey, J A Hall, R A Wright, A G C Sutton, et al.
External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention
Heart, August 1, 2008; 94(8): 1012 - 1018.
[Abstract] [Full Text] [PDF]

C. Berry, P. L. L'Allier, J. Gregoire, J. Lesperance, S. Levesque, R. Ibrahim, and J.-C. Tardif
Comparison of Intravascular Ultrasound and Quantitative Coronary Angiography for the Assessment of Coronary Artery Disease Progression
Circulation, April 10, 2007; 115(14): 1851 - 1857.
[Abstract] [Full Text] [PDF]

V. J. Dzau, E. M. Antman, H. R. Black, D. L. Hayes, J. E. Manson, J. Plutzky, J. J. Popma, and W. Stevenson
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions
Circulation, December 19, 2006; 114(25): 2871 - 2891.
[Full Text] [PDF]

J B Dahm, J Ruppert, S Hartmann, D Vogelgesang, A Hummel, and S B Felix
Directional atherectomy facilitates the interventional procedure and leads to a low rate of recurrent stenosis in left anterior descending and left circumflex artery ostium stenoses: subgroup analysis of the FLEXI-CUT study
Heart, September 1, 2006; 92(9): 1285 - 1289.
[Abstract] [Full Text] [PDF]

M. Adamcova, M. Sterba, T. Simunek, A. Potacova, O. Popelova, and V. Gersl
Myocardial regulatory proteins and heart failure
Eur J Heart Fail, June 1, 2006; 8(4): 333 - 342.
[Abstract] [Full Text] [PDF]

B. G. Brown
Direct Comparison of the A to Z and PROVE IT Trials: A Second Chance to Gain a First Impression
Circulation, March 21, 2006; 113(11): 1382 - 1384.
[Full Text] [PDF]

F. Burzotta, C. Trani, E. Romagnoli, M. A. Mazzari, A. G. Rebuzzi, M. De Vita, B. Garramone, F. Giannico, G. Niccoli, G. G.L. Biondi-Zoccai, et al.
Manual Thrombus-Aspiration Improves Myocardial Reperfusion: The Randomized Evaluation of the Effect of Mechanical Reduction of Distal Embolization by Thrombus-Aspiration in Primary and Rescue Angioplasty (REMEDIA) Trial
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 371 - 376.
[Abstract] [Full Text] [PDF]

A. T. Lovell
Anaesthetic implications of grown-up congenital heart disease
Br. J. Anaesth., July 1, 2004; 93(1): 129 - 139.
[Abstract] [Full Text] [PDF]

M. E. Otto, A. Svatikova, R. B. d. M. Barretto, S. Santos, M. Hoffmann, B. Khandheria, and V. Somers
Early Morning Attenuation of Endothelial Function in Healthy Humans
Circulation, June 1, 2004; 109(21): 2507 - 2510.
[Abstract] [Full Text] [PDF]

B D Thanopoulos, G S Tsaousis, E Karanasios, N G Eleftherakis, and C Paphitis
Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children
Heart, August 1, 2003; 89(8): 918 - 922.
[Abstract] [Full Text] [PDF]

J van der Velden, Z Papp, R Zaremba, N.M Boontje, J.W de Jong, V.J Owen, P.B.J Burton, P Goldmann, K Jaquet, and G.J.M Stienen
Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins
Cardiovasc Res, January 1, 2003; 57(1): 37 - 47.
[Abstract] [Full Text] [PDF]

M. E. Bertrand, M. L. Simoons, K. A.A. Fox, L. C. Wallentin, C. W. Hamm, E. McFadden, P. J. De Feyter, G. Specchia, and W. Ruzyllo
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Eur. Heart J., December 1, 2002; 23(23): 1809 - 1840.
[Full Text] [PDF]

F Burzotta, M Hamon, R Sabatier, F Prati, A Boccanelli, and G Grollier
Large intracoronary thrombi with good TIMI flow during acute myocardial infarction: four cases of successful aggressive medical management in patients without angiographically detectable coronary atherosclerosis
Heart, December 1, 2002; 88(5): e6 - 6.
[Abstract] [Full Text] [PDF]

R. A. Kerensky, M. Wade, P. Deedwania, W. E. Boden, C. J. Pepine, and Veterans Affairs Non-Q-Wave Infarction Strategies
Revisiting the culprit lesion in non-Q-wave myocardial infarction: Results from the VANQWISH trial angiographic core laboratory
J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1456 - 1463.
[Abstract] [Full Text] [PDF]

J. A. Goldstein
Angiographic plaque complexity: the tip of the unstable plaque iceberg
J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1464 - 1467.
[Full Text] [PDF]

G. N. Levine, M. N. Ali, and A. I. Schafer
Antithrombotic Therapy in Patients With Acute Coronary Syndromes
Arch Intern Med, April 9, 2001; 161(7): 937 - 948.
[Abstract] [Full Text] [PDF]

M.E Bertrand, M.L Simoons, K.A.A Fox, L.C Wallentin, C.W Hamm, E McFadden, P.J de Feyter, G Specchia, and W Ruzyllo
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology: Recommendations of the Task Force of the European Society of Cardiology
Eur. Heart J., September 1, 2000; 21(17): 1406 - 1432.
[PDF]

K. P. Rentrop
Thrombi in Acute Coronary Syndromes : Revisited and Revised
Circulation, April 4, 2000; 101(13): 1619 - 1626.
[Full Text] [PDF]

X.-Q. Zhao, P. Theroux, S. M. Snapinn, and F. L. Sax
Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non-Q-Wave Myocardial Infarction : Angiographic Results From the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms)
Circulation, October 12, 1999; 100(15): 1609 - 1615.
[Abstract] [Full Text] [PDF]

G S Kalra, P K Verma, S Singh, and R Arora
Transcatheter closure of ventricular septal defect using detachable steel coil
Heart, September 1, 1999; 82(3): 395 - 396.
[Abstract] [Full Text] [PDF]

N Robinson, K Barakat, and D Dymond
Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus
Heart, April 1, 1999; 81(4): 434 - 437.
[Abstract] [Full Text]

U. Rosenschein, G. Gaul, R. Erbel, F. Amann, D. Velasguez, H. Stoerger, R. Simon, G. Gomez, J. Troster, A. Bartorelli, et al.
Percutaneous Transluminal Therapy of Occluded Saphenous Vein Grafts : Can the Challenge Be Met With Ultrasound Thrombolysis?
Circulation, January 12, 1999; 99(1): 26 - 29.
[Abstract] [Full Text] [PDF]

C. M. Gibson, M. Goel, D. J. Cohen, R. N. Piana, L. I. Deckelbaum, K. E. Harris, S. B. King III, and for the RESTORE Investigators
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 28 - 34.
[Abstract] [Full Text] [PDF]

R. P. Giugliano, C. A. Camargo Jr, D. M. Lloyd-Jones, J. D. Zagrodsky, J. D. Alexis, K. A. Eagle, V. Fuster, and C. J. O'Donnell
Elderly Patients Receive Less Aggressive Medical and Invasive Management of Unstable Angina: Potential Impact of Practice Guidelines
Arch Intern Med, May 25, 1998; 158(10): 1113 - 1120.
[Abstract] [Full Text] [PDF]

G. F. Gensini, M. Comeglio, and A. Colella
Coronary and Peripheral Thrombolysis: Current Status and Recommendations
Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 82 - 86.
[Abstract] [PDF]

P. M. Sanfelippo and D. A. Hector
Considerations in the Surgical Management of Ventricular Septal Defect and Aortic Insufficiency: A Case Report
Angiology, April 1, 1998; 49(4): 321 - 325.
[Abstract] [PDF]

J. I. Haft, S. A. Saadeh, P. Stubbs, P. Collinson, G. X. Brogan, J. E. Hollander, H. Thode, E. V. Carbajal, E. M. Ohman, R. M. Califf, et al.
Cardiac Troponins in Acute Coronary Syndromes
N. Engl. J. Med., April 24, 1997; 336(17): 1257 - 1259.
[Full Text]

T. Ueyama, H. Ikeda, N. Haramaki, K. Kuwano, and T. Imaizumi
Effects of Monoclonal Antibody to P-Selectin and Analogue of Sialyl Lewis X on Cyclic Flow Variations in Stenosed and Endothelium-Injured Canine Coronary Arteries
Circulation, March 18, 1997; 95(6): 1554 - 1559.
[Abstract] [Full Text]

E. M. Antman, M. J. Tanasijevic, B. Thompson, M. Schactman, C. H. McCabe, C. P. Cannon, G. A. Fischer, A. Y. Fung, C. Thompson, D. Wybenga, et al.
Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
N. Engl. J. Med., October 31, 1996; 335(18): 1342 - 1349.
[Abstract] [Full Text] [PDF]

S. Waxman, M. A. Sassower, M. A. Mittleman, S. Zarich, A. Miyamoto, K. S. Manzo, J. E. Muller, G. S. Abela, and R. W. Nesto
Angioscopic Predictors of Early Adverse Outcome After Coronary Angioplasty in Patients With Unstable Angina and Non�Q-Wave Myocardial Infarction
Circulation, June 15, 1996; 93(12): 2106 - 2113.
[Abstract] [Full Text]

E. Falk and V. Fuster
Angina Pectoris and Disease Progression
Circulation, October 15, 1995; 92(8): 2033 - 2035.
[Full Text]

H. Ikeda, Y. Takajo, K. Ichiki, T. Ueno, S. Maki, T. Noda, K. Sugi, and T. Imaizumi
Increased Soluble Form of P-Selectin in Patients With Unstable Angina
Circulation, October 1, 1995; 92(7): 1693 - 1696.
[Abstract] [Full Text]

D. Garcia-Dorado, P. Theroux, P. Tornos, A. Sambola, J. Oliveras, M. Santos, and J. S. Soler
Previous Aspirin Use May Attenuate the Severity of the Manifestation of Acute Ischemic Syndromes
Circulation, October 1, 1995; 92(7): 1743 - 1748.
[Abstract] [Full Text]

J. A. Bittl, J. Strony, J. A. Brinker, W. H. Ahmed, C. R. Meckel, B. R. Chaitman, J. Maraganore, E. Deutsch, B. Adelman, and The Hirulog Angioplasty Study Investigators
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
N. Engl. J. Med., September 21, 1995; 333(12): 764 - 769.
[Abstract] [Full Text] [PDF]

M. W. Wolfe, G. S. Roubin, M. Schweiger, J. M. Isner, J. J. Ferguson, A. D. Cannon, M. Cleman, H. Cabin, F. Leya, R. Bonan, et al.
Length of Hospital Stay and Complications After Percutaneous Transluminal Coronary Angioplasty : Clinical and Procedural Predictors
Circulation, August 1, 1995; 92(3): 311 - 319.
[Abstract] [Full Text]

M. Terplan, S. Kalsner, C.J.M. Cockx, V. K. Somers, M. E. Dyken, and F. M. Abboud
Sympathetic-Nerve Activity during Sleep
N. Engl. J. Med., June 24, 1993; 328(25): 1850 - 1851.
[Full Text]

				G. Sardella, M. Mancone, C. Bucciarelli-Ducci, L. Agati, R. Scardala, I. Carbone, M. Francone, A. Di Roma, G. Benedetti, G. Conti, et al. Thrombus Aspiration During Primary Percutaneous Coronary Intervention Improves Myocardial Reperfusion and Reduces Infarct Size The EXPIRA (Thrombectomy With Export Catheter in Infarct-Related Artery During Primary Percutaneous Coronary Intervention) Prospective, Randomized Trial. J. Am. Coll. Cardiol., January 27, 2009; 53(4): 309 - 315. [Abstract] [Full Text] [PDF]

				B Kunadian, J Dunning, R Das, A P Roberts, R Morley, A J Turley, D Twomey, J A Hall, R A Wright, A G C Sutton, et al. External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention Heart, August 1, 2008; 94(8): 1012 - 1018. [Abstract] [Full Text] [PDF]

				C. Berry, P. L. L'Allier, J. Gregoire, J. Lesperance, S. Levesque, R. Ibrahim, and J.-C. Tardif Comparison of Intravascular Ultrasound and Quantitative Coronary Angiography for the Assessment of Coronary Artery Disease Progression Circulation, April 10, 2007; 115(14): 1851 - 1857. [Abstract] [Full Text] [PDF]

				V. J. Dzau, E. M. Antman, H. R. Black, D. L. Hayes, J. E. Manson, J. Plutzky, J. J. Popma, and W. Stevenson The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions Circulation, December 19, 2006; 114(25): 2871 - 2891. [Full Text] [PDF]

				J B Dahm, J Ruppert, S Hartmann, D Vogelgesang, A Hummel, and S B Felix Directional atherectomy facilitates the interventional procedure and leads to a low rate of recurrent stenosis in left anterior descending and left circumflex artery ostium stenoses: subgroup analysis of the FLEXI-CUT study Heart, September 1, 2006; 92(9): 1285 - 1289. [Abstract] [Full Text] [PDF]

				M. Adamcova, M. Sterba, T. Simunek, A. Potacova, O. Popelova, and V. Gersl Myocardial regulatory proteins and heart failure Eur J Heart Fail, June 1, 2006; 8(4): 333 - 342. [Abstract] [Full Text] [PDF]

				B. G. Brown Direct Comparison of the A to Z and PROVE IT Trials: A Second Chance to Gain a First Impression Circulation, March 21, 2006; 113(11): 1382 - 1384. [Full Text] [PDF]

				F. Burzotta, C. Trani, E. Romagnoli, M. A. Mazzari, A. G. Rebuzzi, M. De Vita, B. Garramone, F. Giannico, G. Niccoli, G. G.L. Biondi-Zoccai, et al. Manual Thrombus-Aspiration Improves Myocardial Reperfusion: The Randomized Evaluation of the Effect of Mechanical Reduction of Distal Embolization by Thrombus-Aspiration in Primary and Rescue Angioplasty (REMEDIA) Trial J. Am. Coll. Cardiol., July 19, 2005; 46(2): 371 - 376. [Abstract] [Full Text] [PDF]

				A. T. Lovell Anaesthetic implications of grown-up congenital heart disease Br. J. Anaesth., July 1, 2004; 93(1): 129 - 139. [Abstract] [Full Text] [PDF]

				M. E. Otto, A. Svatikova, R. B. d. M. Barretto, S. Santos, M. Hoffmann, B. Khandheria, and V. Somers Early Morning Attenuation of Endothelial Function in Healthy Humans Circulation, June 1, 2004; 109(21): 2507 - 2510. [Abstract] [Full Text] [PDF]

				B D Thanopoulos, G S Tsaousis, E Karanasios, N G Eleftherakis, and C Paphitis Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children Heart, August 1, 2003; 89(8): 918 - 922. [Abstract] [Full Text] [PDF]

				J van der Velden, Z Papp, R Zaremba, N.M Boontje, J.W de Jong, V.J Owen, P.B.J Burton, P Goldmann, K Jaquet, and G.J.M Stienen Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins Cardiovasc Res, January 1, 2003; 57(1): 37 - 47. [Abstract] [Full Text] [PDF]

				M. E. Bertrand, M. L. Simoons, K. A.A. Fox, L. C. Wallentin, C. W. Hamm, E. McFadden, P. J. De Feyter, G. Specchia, and W. Ruzyllo Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur. Heart J., December 1, 2002; 23(23): 1809 - 1840. [Full Text] [PDF]

				F Burzotta, M Hamon, R Sabatier, F Prati, A Boccanelli, and G Grollier Large intracoronary thrombi with good TIMI flow during acute myocardial infarction: four cases of successful aggressive medical management in patients without angiographically detectable coronary atherosclerosis Heart, December 1, 2002; 88(5): e6 - 6. [Abstract] [Full Text] [PDF]

				R. A. Kerensky, M. Wade, P. Deedwania, W. E. Boden, C. J. Pepine, and Veterans Affairs Non-Q-Wave Infarction Strategies Revisiting the culprit lesion in non-Q-wave myocardial infarction: Results from the VANQWISH trial angiographic core laboratory J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1456 - 1463. [Abstract] [Full Text] [PDF]

				J. A. Goldstein Angiographic plaque complexity: the tip of the unstable plaque iceberg J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1464 - 1467. [Full Text] [PDF]

				G. N. Levine, M. N. Ali, and A. I. Schafer Antithrombotic Therapy in Patients With Acute Coronary Syndromes Arch Intern Med, April 9, 2001; 161(7): 937 - 948. [Abstract] [Full Text] [PDF]

				M.E Bertrand, M.L Simoons, K.A.A Fox, L.C Wallentin, C.W Hamm, E McFadden, P.J de Feyter, G Specchia, and W Ruzyllo Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology: Recommendations of the Task Force of the European Society of Cardiology Eur. Heart J., September 1, 2000; 21(17): 1406 - 1432. [PDF]

				K. P. Rentrop Thrombi in Acute Coronary Syndromes : Revisited and Revised Circulation, April 4, 2000; 101(13): 1619 - 1626. [Full Text] [PDF]

				X.-Q. Zhao, P. Theroux, S. M. Snapinn, and F. L. Sax Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non-Q-Wave Myocardial Infarction : Angiographic Results From the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms) Circulation, October 12, 1999; 100(15): 1609 - 1615. [Abstract] [Full Text] [PDF]

				G S Kalra, P K Verma, S Singh, and R Arora Transcatheter closure of ventricular septal defect using detachable steel coil Heart, September 1, 1999; 82(3): 395 - 396. [Abstract] [Full Text] [PDF]

				N Robinson, K Barakat, and D Dymond Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus Heart, April 1, 1999; 81(4): 434 - 437. [Abstract] [Full Text]

				U. Rosenschein, G. Gaul, R. Erbel, F. Amann, D. Velasguez, H. Stoerger, R. Simon, G. Gomez, J. Troster, A. Bartorelli, et al. Percutaneous Transluminal Therapy of Occluded Saphenous Vein Grafts : Can the Challenge Be Met With Ultrasound Thrombolysis? Circulation, January 12, 1999; 99(1): 26 - 29. [Abstract] [Full Text] [PDF]

				C. M. Gibson, M. Goel, D. J. Cohen, R. N. Piana, L. I. Deckelbaum, K. E. Harris, S. B. King III, and for the RESTORE Investigators Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial J. Am. Coll. Cardiol., July 1, 1998; 32(1): 28 - 34. [Abstract] [Full Text] [PDF]

				R. P. Giugliano, C. A. Camargo Jr, D. M. Lloyd-Jones, J. D. Zagrodsky, J. D. Alexis, K. A. Eagle, V. Fuster, and C. J. O'Donnell Elderly Patients Receive Less Aggressive Medical and Invasive Management of Unstable Angina: Potential Impact of Practice Guidelines Arch Intern Med, May 25, 1998; 158(10): 1113 - 1120. [Abstract] [Full Text] [PDF]

				G. F. Gensini, M. Comeglio, and A. Colella Coronary and Peripheral Thrombolysis: Current Status and Recommendations Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 82 - 86. [Abstract] [PDF]

				P. M. Sanfelippo and D. A. Hector Considerations in the Surgical Management of Ventricular Septal Defect and Aortic Insufficiency: A Case Report Angiology, April 1, 1998; 49(4): 321 - 325. [Abstract] [PDF]

				J. I. Haft, S. A. Saadeh, P. Stubbs, P. Collinson, G. X. Brogan, J. E. Hollander, H. Thode, E. V. Carbajal, E. M. Ohman, R. M. Califf, et al. Cardiac Troponins in Acute Coronary Syndromes N. Engl. J. Med., April 24, 1997; 336(17): 1257 - 1259. [Full Text]

				T. Ueyama, H. Ikeda, N. Haramaki, K. Kuwano, and T. Imaizumi Effects of Monoclonal Antibody to P-Selectin and Analogue of Sialyl Lewis X on Cyclic Flow Variations in Stenosed and Endothelium-Injured Canine Coronary Arteries Circulation, March 18, 1997; 95(6): 1554 - 1559. [Abstract] [Full Text]

				E. M. Antman, M. J. Tanasijevic, B. Thompson, M. Schactman, C. H. McCabe, C. P. Cannon, G. A. Fischer, A. Y. Fung, C. Thompson, D. Wybenga, et al. Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes N. Engl. J. Med., October 31, 1996; 335(18): 1342 - 1349. [Abstract] [Full Text] [PDF]